Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-2

ClinicalTrials.gov ID: NCT05836220

Public ClinicalTrials.gov record NCT05836220. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Dose-Titrated PLS240 in the Treatment of Secondary Hyperparathyroidism in Individuals With End Stage Kidney Disease on Hemodialysis (PATH-2) With an Open-Label Extension

Study identification

NCT ID
NCT05836220
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pathalys Pharma
Industry
Enrollment
412 participants

Conditions and interventions

Interventions

  • PLS240 Drug
  • Placebo Drug
  • Open-Label Extension PLS240 Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 14, 2023
Primary completion
Aug 4, 2025
Completion
Aug 4, 2025
Last update posted
Sep 8, 2025

2023 – 2025

United States locations

U.S. sites
50
U.S. states
20
U.S. cities
46
Facility City State ZIP Site status
Site Number: USA039-2 Anaheim California 92801-6731
Site Number: USA001-2 Chula Vista California 91910-3813
Site Number: USA020-2 Escondido California 92025-4402
Site Number: USA042-2 Fresno California 93720-3389
Site Number: USA034-2 Fullerton California 92832-3037
Site Number: USA046-2 Glendale California 91205-3313
Site Number: USA019-2 Granada Hills California 91344-7407
Site Number: USA005-2 La Mesa California 91942-3017
Site Number: USA044-2 Lancaster California 93534-2831
Site Number: USA030-2 Los Angeles California 90022-4302
Site Number: USA043-2 Los Angeles California 90033
Site Number: USA022-2 Moorpark California 93021-3352
Site Number: USA049-2 Northridge California 91324-2927
Site Number: USA033-2 Northridge California 91324-3528
Site Number: USA003-2 San Diego California 92111-3636
Site Number: USA018-2 San Dimas California 91773-3539
Site Number: USA056-2 Tarzana California 91356-2806
Site Number: USA021-2 Tarzana California 91356-3647
Site Number: USA052-2 Victorville California 92395-8322
Site Number: USA023-2 Arvada Colorado 80002-3714
Site Number: USA031-2 Aurora Colorado 80045-7202
Site Number: USA017-2 Middlebury Connecticut 06762-2843
Site Number: USA015-2 Newark Delaware 19713-2081
Site Number: USA004-2 Fort Myers Florida 33908-4154
Site Number: USA002-2 Hollywood Florida 33024-2776
Site Number: USA041-2 Orlando Florida 32801
Site Number: USA035-2 South Miami Florida 33143-5522
Site Number: USA013-2 Columbus Georgia 31904-3603
Site Number: USA028-2 Mishawaka Indiana 46545-3519
Site Number: USA024-2 Wichita Kansas 67214-2944
Site Number: USA054-2 New Orleans Louisiana 70112
Site Number: USA048-2 Detroit Michigan 48236-2169
Site Number: USA025-2 Kalamazoo Michigan 49007-3889
Site Number: USA016-2 Minneapolis Minnesota 55404-1212
Site Number: USA007-2 Amherst New York 14228-2792
Site Number: USA053-2 Charlotte North Carolina 28208-3876
Site Number: USA026-2 Durham North Carolina 27704-2147
Site Number: USA009-2 Toledo Ohio 43606-1171
Site Number: USA045-2 Roseburg Oregon 97471-6214
Site Number: USA010-2 Greenville South Carolina 29605-4019
Site Number: USA027-2 Knoxville Tennessee 37923-3624
Site Number: USA011-2 El Paso Texas 79925-4828
Site Number: USA029-2 Live Oak Texas 78233-4767
Site Number: USA055-2 Prosper Texas 75078-1411
Site Number: USA012-2 San Antonio Texas 78221-3019
Site Number: USA008-2 San Antonio Texas 78251-4125
Site Number: USA006-2 Waxahachie Texas 75165-1399
Site Number: USA038-2 St. George Utah 84790-5898
Site Number: USA051-2 Fairfax Virginia 22033-1907
Site Number: USA037-2 Norfolk Virginia 23507-1901

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05836220, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 8, 2025 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05836220 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →